S&S Healthcare Holding マネジメント

マネジメント基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	no data
CEOの所有権	n/a
経営陣の平均在職期間	データなし
取締役会の平均在任期間	データなし

経営陣の近況

Recent updates

Here's Why S&S Healthcare Holding (GTSM:4198) Can Afford Some Debt

Apr 22

Is S&S Healthcare Holding (GTSM:4198) A Risky Investment?

Jan 07

CEO（最高経営責任者

S&S Healthcare Holding CEOがいない、あるいは彼らに関するデータがない。

S&S Healthcare Holding マネジメント

マネジメント基準チェック /04

主要情報

経営陣の近況

S&S Healthcare Holding Ltd., Annual General Meeting, Jun 20, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: NT$0.57 loss per share (vs NT$0.41 loss in 3Q 2023)

Investor sentiment improves as stock rises 18%

Second quarter 2024 earnings released: NT$0.51 loss per share (vs NT$1.06 loss in 2Q 2023)

Investor sentiment improves as stock rises 23%

First quarter 2024 earnings released: NT$0.79 loss per share (vs NT$0.60 loss in 1Q 2023)

S&S Healthcare Holding Ltd., Annual General Meeting, Jun 20, 2024

Investor sentiment improves as stock rises 20%

Full year 2023 earnings released: EPS: NT$4.49 (vs NT$3.77 loss in FY 2022)

New minor risk - Share price stability

Second quarter 2023 earnings released: NT$1.06 loss per share (vs NT$1.10 loss in 2Q 2022)

Full year 2022 earnings released: NT$3.77 loss per share (vs NT$6.52 loss in FY 2021)

Less than half of directors are independent

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Third quarter 2021 earnings released: NT$0.37 loss per share (vs NT$0.36 loss in 3Q 2020)

Second quarter 2021 earnings released: NT$0.24 loss per share (vs NT$0.55 loss in 2Q 2020)

Here's Why S&S Healthcare Holding (GTSM:4198) Can Afford Some Debt

Full year 2020 earnings released: NT$1.87 loss per share (vs NT$3.58 loss in FY 2019)

Is S&S Healthcare Holding (GTSM:4198) A Risky Investment?

New 90-day low: NT$7.16

Third quarter 2020 earnings released: NT$0.36 loss per share

New 90-day high: NT$14.50

New 90-day high - NT$7.35

CEO（最高経営責任者

S&S Healthcare Holding マネジメント

マネジメント 基準チェック /04

主要情報

経営陣の近況

S&S Healthcare Holding Ltd., Annual General Meeting, Jun 20, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: NT$0.57 loss per share (vs NT$0.41 loss in 3Q 2023)

Investor sentiment improves as stock rises 18%

Second quarter 2024 earnings released: NT$0.51 loss per share (vs NT$1.06 loss in 2Q 2023)

Investor sentiment improves as stock rises 23%

First quarter 2024 earnings released: NT$0.79 loss per share (vs NT$0.60 loss in 1Q 2023)

S&S Healthcare Holding Ltd., Annual General Meeting, Jun 20, 2024

Investor sentiment improves as stock rises 20%

Full year 2023 earnings released: EPS: NT$4.49 (vs NT$3.77 loss in FY 2022)

New minor risk - Share price stability

Second quarter 2023 earnings released: NT$1.06 loss per share (vs NT$1.10 loss in 2Q 2022)

Full year 2022 earnings released: NT$3.77 loss per share (vs NT$6.52 loss in FY 2021)

Less than half of directors are independent

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Third quarter 2021 earnings released: NT$0.37 loss per share (vs NT$0.36 loss in 3Q 2020)

Second quarter 2021 earnings released: NT$0.24 loss per share (vs NT$0.55 loss in 2Q 2020)

Here's Why S&S Healthcare Holding (GTSM:4198) Can Afford Some Debt

Full year 2020 earnings released: NT$1.87 loss per share (vs NT$3.58 loss in FY 2019)

Is S&S Healthcare Holding (GTSM:4198) A Risky Investment?

New 90-day low: NT$7.16

Third quarter 2020 earnings released: NT$0.36 loss per share

New 90-day high: NT$14.50

New 90-day high - NT$7.35

CEO（最高経営責任者

マネジメント基準チェック /04